However, whether MSI2 plays a role in IBD or has regulatory effects on innate and adaptive immunity has not been reported, and whether MSI2 deletion in ILC3s can alter the immune response and affect the composition of the intestinal microbiota remains unknown. The gene discussed is MSI2; the disease is inflammatory bowel disease.